nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—NR0B1—female reproductive system—vaginal cancer	0.0318	0.0318	CbGeAlD
Dexamethasone—PLA2G1B—epithelium—vaginal cancer	0.0305	0.0305	CbGeAlD
Dexamethasone—NR0B1—female gonad—vaginal cancer	0.029	0.029	CbGeAlD
Dexamethasone—CYP4A11—vagina—vaginal cancer	0.0248	0.0248	CbGeAlD
Dexamethasone—ANXA1—epithelium—vaginal cancer	0.0233	0.0233	CbGeAlD
Dexamethasone—ANXA1—uterine cervix—vaginal cancer	0.0231	0.0231	CbGeAlD
Dexamethasone—PLA2G1B—female reproductive system—vaginal cancer	0.0227	0.0227	CbGeAlD
Dexamethasone—ANXA1—urethra—vaginal cancer	0.0213	0.0213	CbGeAlD
Dexamethasone—ANXA1—endometrium—vaginal cancer	0.0209	0.0209	CbGeAlD
Dexamethasone—PLA2G1B—female gonad—vaginal cancer	0.0206	0.0206	CbGeAlD
Dexamethasone—ANXA1—mammalian vulva—vaginal cancer	0.0203	0.0203	CbGeAlD
Dexamethasone—ANXA1—uterus—vaginal cancer	0.0193	0.0193	CbGeAlD
Dexamethasone—ANXA1—female reproductive system—vaginal cancer	0.0173	0.0173	CbGeAlD
Dexamethasone—ANXA1—female gonad—vaginal cancer	0.0158	0.0158	CbGeAlD
Dexamethasone—ANXA1—vagina—vaginal cancer	0.0157	0.0157	CbGeAlD
Dexamethasone—CYP17A1—female reproductive system—vaginal cancer	0.0155	0.0155	CbGeAlD
Dexamethasone—NR3C2—uterine cervix—vaginal cancer	0.015	0.015	CbGeAlD
Dexamethasone—CYP11A1—female reproductive system—vaginal cancer	0.0145	0.0145	CbGeAlD
Dexamethasone—CYP17A1—female gonad—vaginal cancer	0.0141	0.0141	CbGeAlD
Dexamethasone—PGR—epithelium—vaginal cancer	0.0141	0.0141	CbGeAlD
Dexamethasone—PGR—uterine cervix—vaginal cancer	0.0139	0.0139	CbGeAlD
Dexamethasone—NR3C2—urethra—vaginal cancer	0.0138	0.0138	CbGeAlD
Dexamethasone—NR3C2—endometrium—vaginal cancer	0.0136	0.0136	CbGeAlD
Dexamethasone—CYP11A1—female gonad—vaginal cancer	0.0132	0.0132	CbGeAlD
Dexamethasone—NR3C2—mammalian vulva—vaginal cancer	0.0131	0.0131	CbGeAlD
Dexamethasone—PGR—endometrium—vaginal cancer	0.0126	0.0126	CbGeAlD
Dexamethasone—NR3C2—uterus—vaginal cancer	0.0125	0.0125	CbGeAlD
Dexamethasone—PGR—uterus—vaginal cancer	0.0116	0.0116	CbGeAlD
Dexamethasone—CYP19A1—endometrium—vaginal cancer	0.0113	0.0113	CbGeAlD
Dexamethasone—NR3C2—female reproductive system—vaginal cancer	0.0112	0.0112	CbGeAlD
Dexamethasone—CYP2A6—vagina—vaginal cancer	0.0108	0.0108	CbGeAlD
Dexamethasone—CYP19A1—uterus—vaginal cancer	0.0105	0.0105	CbGeAlD
Dexamethasone—PGR—female reproductive system—vaginal cancer	0.0104	0.0104	CbGeAlD
Dexamethasone—NR3C2—female gonad—vaginal cancer	0.0102	0.0102	CbGeAlD
Dexamethasone—NR3C2—vagina—vaginal cancer	0.0102	0.0102	CbGeAlD
Dexamethasone—CYP1B1—uterus—vaginal cancer	0.00977	0.00977	CbGeAlD
Dexamethasone—PGR—female gonad—vaginal cancer	0.0095	0.0095	CbGeAlD
Dexamethasone—PGR—vagina—vaginal cancer	0.00944	0.00944	CbGeAlD
Dexamethasone—CYP19A1—female reproductive system—vaginal cancer	0.00939	0.00939	CbGeAlD
Dexamethasone—ABCC2—female reproductive system—vaginal cancer	0.00897	0.00897	CbGeAlD
Dexamethasone—CYP1B1—female reproductive system—vaginal cancer	0.00878	0.00878	CbGeAlD
Dexamethasone—ABCG2—uterine cervix—vaginal cancer	0.00873	0.00873	CbGeAlD
Dexamethasone—CYP19A1—female gonad—vaginal cancer	0.00855	0.00855	CbGeAlD
Dexamethasone—CYP1A1—epithelium—vaginal cancer	0.00836	0.00836	CbGeAlD
Dexamethasone—CYP1A1—uterine cervix—vaginal cancer	0.00829	0.00829	CbGeAlD
Dexamethasone—CYP2C8—endometrium—vaginal cancer	0.00812	0.00812	CbGeAlD
Dexamethasone—NR3C1—epithelium—vaginal cancer	0.00811	0.00811	CbGeAlD
Dexamethasone—CYP3A5—uterine cervix—vaginal cancer	0.0081	0.0081	CbGeAlD
Dexamethasone—NR3C1—uterine cervix—vaginal cancer	0.00804	0.00804	CbGeAlD
Dexamethasone—ABCG2—urethra—vaginal cancer	0.00802	0.00802	CbGeAlD
Dexamethasone—CYP1B1—female gonad—vaginal cancer	0.00799	0.00799	CbGeAlD
Dexamethasone—ABCG2—endometrium—vaginal cancer	0.00789	0.00789	CbGeAlD
Dexamethasone—ABCG2—mammalian vulva—vaginal cancer	0.00764	0.00764	CbGeAlD
Dexamethasone—CYP1A1—urethra—vaginal cancer	0.00762	0.00762	CbGeAlD
Dexamethasone—NR3C1—urethra—vaginal cancer	0.00739	0.00739	CbGeAlD
Dexamethasone—ABCG2—uterus—vaginal cancer	0.00727	0.00727	CbGeAlD
Dexamethasone—NR3C1—endometrium—vaginal cancer	0.00727	0.00727	CbGeAlD
Dexamethasone—CYP1A1—mammalian vulva—vaginal cancer	0.00725	0.00725	CbGeAlD
Dexamethasone—NR3C1—mammalian vulva—vaginal cancer	0.00703	0.00703	CbGeAlD
Dexamethasone—PTGS2—epithelium—vaginal cancer	0.00702	0.00702	CbGeAlD
Dexamethasone—CYP2C19—vagina—vaginal cancer	0.00697	0.00697	CbGeAlD
Dexamethasone—PTGS2—uterine cervix—vaginal cancer	0.00696	0.00696	CbGeAlD
Dexamethasone—CYP2E1—urethra—vaginal cancer	0.00694	0.00694	CbGeAlD
Dexamethasone—CYP1A1—uterus—vaginal cancer	0.00691	0.00691	CbGeAlD
Dexamethasone—CYP2C8—female reproductive system—vaginal cancer	0.00673	0.00673	CbGeAlD
Dexamethasone—NR3C1—uterus—vaginal cancer	0.0067	0.0067	CbGeAlD
Dexamethasone—PTGS2—urethra—vaginal cancer	0.00639	0.00639	CbGeAlD
Dexamethasone—PTGS2—endometrium—vaginal cancer	0.00629	0.00629	CbGeAlD
Dexamethasone—CYP1A1—female reproductive system—vaginal cancer	0.00621	0.00621	CbGeAlD
Dexamethasone—CYP2C8—vagina—vaginal cancer	0.00608	0.00608	CbGeAlD
Dexamethasone—CYP2B6—female reproductive system—vaginal cancer	0.00603	0.00603	CbGeAlD
Dexamethasone—NR3C1—female reproductive system—vaginal cancer	0.00602	0.00602	CbGeAlD
Dexamethasone—CYP2C9—female reproductive system—vaginal cancer	0.00597	0.00597	CbGeAlD
Dexamethasone—ABCG2—female gonad—vaginal cancer	0.00595	0.00595	CbGeAlD
Dexamethasone—ABCG2—vagina—vaginal cancer	0.00591	0.00591	CbGeAlD
Dexamethasone—PTGS2—uterus—vaginal cancer	0.0058	0.0058	CbGeAlD
Dexamethasone—CYP2E1—female reproductive system—vaginal cancer	0.00566	0.00566	CbGeAlD
Dexamethasone—CYP1A1—female gonad—vaginal cancer	0.00565	0.00565	CbGeAlD
Dexamethasone—CYP1A1—vagina—vaginal cancer	0.00562	0.00562	CbGeAlD
Dexamethasone—CYP3A5—female gonad—vaginal cancer	0.00552	0.00552	CbGeAlD
Dexamethasone—CYP3A5—vagina—vaginal cancer	0.00549	0.00549	CbGeAlD
Dexamethasone—NR3C1—female gonad—vaginal cancer	0.00548	0.00548	CbGeAlD
Dexamethasone—CYP2B6—vagina—vaginal cancer	0.00546	0.00546	CbGeAlD
Dexamethasone—NR3C1—vagina—vaginal cancer	0.00545	0.00545	CbGeAlD
Dexamethasone—PTGS2—female reproductive system—vaginal cancer	0.00521	0.00521	CbGeAlD
Dexamethasone—PTGS2—female gonad—vaginal cancer	0.00474	0.00474	CbGeAlD
Dexamethasone—PTGS2—vagina—vaginal cancer	0.00472	0.00472	CbGeAlD
Dexamethasone—CYP3A4—female reproductive system—vaginal cancer	0.00456	0.00456	CbGeAlD
Dexamethasone—CYP2D6—female reproductive system—vaginal cancer	0.00448	0.00448	CbGeAlD
Dexamethasone—ABCB1—epithelium—vaginal cancer	0.00434	0.00434	CbGeAlD
Dexamethasone—ABCB1—uterine cervix—vaginal cancer	0.0043	0.0043	CbGeAlD
Dexamethasone—CYP2D6—female gonad—vaginal cancer	0.00408	0.00408	CbGeAlD
Dexamethasone—ABCB1—urethra—vaginal cancer	0.00396	0.00396	CbGeAlD
Dexamethasone—ABCB1—endometrium—vaginal cancer	0.00389	0.00389	CbGeAlD
Dexamethasone—ABCB1—mammalian vulva—vaginal cancer	0.00377	0.00377	CbGeAlD
Dexamethasone—ABCB1—uterus—vaginal cancer	0.00359	0.00359	CbGeAlD
Dexamethasone—ABCB1—female reproductive system—vaginal cancer	0.00322	0.00322	CbGeAlD
Dexamethasone—ABCB1—female gonad—vaginal cancer	0.00293	0.00293	CbGeAlD
Dexamethasone—ABCB1—vagina—vaginal cancer	0.00292	0.00292	CbGeAlD
